Iron-Deficiency Anemia: The Evidence-Based Supplement Protocol
Iron-deficiency anemia is the rare case where the supplement is the treatment — but only after a clinician finds the cause of the iron loss, since new anemia in older adults can be the first sign of a GI cancer. The biggest evidence shift is dosing: a single morning dose of about 60–120 mg elemental iron every other day absorbs better than splitting it through the day, with fewer side effects. Gentler salts such as ferrous bisglycinate can match ferrous sulfate at lower elemental doses, which matters mainly for tolerability and adherence. Routine added vitamin C is optional — a recent RCT found it did not improve recovery — while separating iron from coffee, tea, calcium, and antacids genuinely helps, and repletion should continue 3–6 months after hemoglobin normalizes to refill stores.
Iron-deficiency anemia (IDA) is the rare scenario where the "supplement" is the treatment, not an adjunct—but only after the cause of the iron loss is found. That caveat is the most important sentence on this page: IDA is a sign, not a diagnosis, and the underlying cause (heavy menstruation, gastrointestinal bleeding, malabsorption such as celiac disease, or inadequate intake) must be identified, because in older adults and post-menopausal women new IDA can be the first sign of a GI cancer. With the cause being worked up, the goal of supplementation is to replace iron with the most absorption and the fewest side effects. Two evidence shifts matter: alternate-day, single-morning dosing now appears to absorb better than splitting iron through the day, and gentler salts such as ferrous bisglycinate can match ferrous sulfate at lower elemental doses. Here is the evidence-based way to run repletion, and what the latest trials say to drop.
Oral Iron, ~60–120 mg Elemental Every Other Day — Strong Evidence
Oral iron is the first-line treatment for IDA, and the dosing has been refined by landmark physiology. In two open-label randomized trials in iron-depleted women, giving iron on consecutive days raised the iron-regulating hormone hepcidin and lowered fractional absorption from the next dose, whereas alternate-day single-morning dosing produced higher cumulative absorption (21.8% vs 16.3% fractional absorption; both p<0.01). Twice-daily split dosing was no better than once daily and raised hepcidin further. The practical translation: a single morning dose of roughly 60–120 mg elemental iron every other day often delivers as much absorbed iron as daily dosing, with fewer GI side effects. Repletion is a marathon—hemoglobin typically starts rising within 2–4 weeks, but you continue for 3–6 months after it normalizes to refill ferritin stores. (These were absorption studies in non-anemic women; clinical guidelines still individualize dosing, and some anemic patients need daily iron.)
Iron Form: Ferrous Bisglycinate vs Ferrous Sulfate — Tolerability, Not Efficacy
Traditional ferrous sulfate is effective and cheap, but its elemental load drives nausea, cramping, and constipation that wreck adherence—and the best iron salt is the one a patient will actually keep taking. A large systematic review of oral-iron tolerability (111 studies, >10,000 patients) found wide variation in adverse-event rates between formulations, with conventional ferrous sulfate among the worse-tolerated and chelated/slow-release forms better tolerated. Ferrous bisglycinate is a chelated form absorbed well at lower elemental doses and is typically gentler on the gut; ferrous gluconate is an intermediate option. The choice is mostly about tolerability rather than a large efficacy gap. See our ferrous bisglycinate vs sulfate comparison and the iron forms guide.
Vitamin C — Largely Unnecessary, Per the Latest RCT
Ascorbic acid keeps iron in its more-absorbable ferrous state and increases non-heme iron uptake from a single meal in absorption studies, which is why iron is classically taken with orange juice or a vitamin C tablet. But the clinical payoff is smaller than the folklore suggests. An open-label equivalence RCT in 440 adults with IDA compared oral iron plus 200 mg vitamin C against iron alone: the two were equivalent for hemoglobin recovery at two weeks (between-group difference 0.16 g/dL; 95% CI −0.03 to 0.35) and for ferritin at eight weeks, with no difference in side effects. The authors concluded routine vitamin C is not essential alongside oral iron. Treat added vitamin C as optional, not a requirement. Far more useful is timing: separate iron from coffee, tea, calcium, and antacids/PPIs by a couple of hours, since those genuinely blunt absorption.
Lactoferrin, ~100–250 mg Daily — Limited (Tolerability Alternative)
Lactoferrin, an iron-binding milk glycoprotein, is an option when oral iron salts are intolerable. A systematic review and meta-analysis of randomized trials found oral bovine lactoferrin raised hemoglobin more than ferrous sulfate in low-hemoglobin patients (standardized mean difference favoring lactoferrin), with fewer GI side effects and better adherence—but the included trials were heterogeneous and of mixed quality (high statistical heterogeneity), so the size of the advantage is uncertain. It is more expensive than iron salts, so it is best seen as a second-line tolerability play—reasonable for pregnant patients or anyone who simply cannot stomach conventional iron—rather than a routine first choice.
What Does Not Work, or Is Overhyped
Do not start iron without confirming deficiency (low ferritin) and pursuing the cause—treating anemia of chronic disease, or worse an undiagnosed GI malignancy, with iron is a dangerous miss; guidelines recommend endoscopic evaluation in men and post-menopausal women with new IDA. Avoid twice-daily split dosing and very high single doses; both raise hepcidin and reduce net absorption while worsening side effects. "Gentle" food-iron blends, blackstrap molasses, and beetroot do not reliably correct true anemia. Do not take iron with calcium, coffee, tea, or PPIs. Critically, never store adult iron supplements where young children can reach them—iron overdose is a leading cause of pediatric poisoning deaths. And do not self-supplement indefinitely once stores are full: iron overload is harmful, especially in men and in hereditary hemochromatosis.
How to Run the Protocol
Confirm IDA with ferritin and pursue a cause work-up first. Then start ~60–120 mg elemental iron (ferrous bisglycinate if tolerability is a concern) as a single morning dose every other day; a vitamin C source is optional. Keep it away from coffee, tea, dairy, and acid-suppressing drugs. Recheck hemoglobin and reticulocytes at 2–4 weeks and ferritin at ~3 months; continue 3–6 months past hemoglobin normalization to rebuild stores. If oral iron is intolerable or absorption is poor (celiac disease, prior bariatric surgery, ongoing inflammation), discuss lactoferrin or modern intravenous iron with your clinician rather than pushing the oral dose higher—IV iron is now a fast, safe way to replace a full deficit when oral iron fails.
Sources
- Stoffel NU, Cercamondi CI, Brittenham G, et al. "Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials." The Lancet Haematology, 2017;4(11):e524-e533. PMID 29032957.
- Li N, Zhao G, Wu W, et al. "The efficacy and safety of vitamin C for iron supplementation in adult patients with iron deficiency anemia: a randomized clinical trial." JAMA Network Open, 2020;3(11):e2023644. PMID 33136134.
- Christofi MD, Giannakou K, Mpouzika M, Merkouris A, Vergoulidou-Stylianide M, Charalambous A. "The effectiveness of oral bovine lactoferrin compared to iron supplementation in patients with a low hemoglobin profile: a systematic review and meta-analysis of randomized clinical trials." BMC Nutrition, 2024;10(1):20. PMID 38291525.
- Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. "Tolerability of different oral iron supplements: a systematic review." Current Medical Research and Opinion, 2013;29(4):291-303. PMID 23252877.
- Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. "Iron deficiency." The Lancet, 2021;397(10270):233-248. PMID 33285139.